Medicared For All Logo

James Gerson in Burlington, Vermont

Home Vermont Burlington

James Gerson has Medical Oncology as his primary medical specialty. Their primary office is: 111 Colchester Ave in Burlington, Vermont.

They're a part of the: University Of Vermont Medical Center Inc medical group which has around 992 members. You can call their office at 802-847-0000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2012 (around 12 years of experience). They are listed as doing telehealth appointments.


James N Gerson Office Phone and Directions

James Gerson
University Of Vermont Medical Center Inc
111 Colchester Ave
Burlington, Vermont 05401
802-847-0000


Patient Ratings
Please rate your experience with James Gerson below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 802-847-0000


Enter a starting address:


Healthcare Info for James Gerson

Additional Medical Specialties Include:
HEMATOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 2012
The Primary Medical Specialty for James Gerson is listed as: Medical Oncology
Approximate Years of Experience: 12
PAC (PECOS ID)#: 1951656693
NPI #: 1336406040
NPI Created On: 04/19/2012
NPI Last Updated Listed as: 09/22/2022
Primary Taxonomy Code: 207R00000X
License Number:
MD455131
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • Highmark Health Insurance Company
  • Highmark Inc.
  • Pennsylvania Health & Wellness, Inc.
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. New patient office or other outpatient visit, typically 60 minutes
  2. Established patient office or other outpatient visit, typically 15 minutes
  3. Established patient office or other outpatient, visit typically 25 minutes
  4. Established patient office or other outpatient, visit typically 40 minutes
  5. Initial hospital inpatient care, typically 70 minutes per day
  6. Subsequent hospital inpatient care, typically 25 minutes per day
  7. Subsequent hospital inpatient care, typically 35 minutes per day
  8. Prolonged office or other outpatient service first hour
  9. Prolonged patient service without direct patient contact first hour
  10. Advance care planning by the physician or other qualified health care professional

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $225

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 794579799

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22


Payments Total: $1,125

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 794579803

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22


Payments Total: $100

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Payment was made by a third party for participation in a market research study on behalf of GSK.

Record ID:: 803141329

Being Disputed:: No

Product Related: No


Payments Total: $683

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835922097

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0579-28


Payments Total: $1,365

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835922101

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0579-28


Payments Total: $2,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: ;KP26101;KPSCIM;13158490

Record ID:: 844413965

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CELLT

Name of Drug #1: Tecartus

Open Associated Drug #1: 71287-219-02


Medical Oncology Professionals in Burlington

111 Colchester Ave
Burlington, VT
University Of Vermont Medical Center Inc

111 Colchester Ave
Burlington, VT
University Of Vermont Medical Center Inc

111 Colchester Ave
Burlington, VT
University Of Vermont Medical Center Inc

1 S Prospect St
Burlington, VT
University Of Vermont Medical Center Inc

111 Colchester Ave
Burlington, VT
University Of Vermont Medical Center Inc

111 Colchester Ave
Burlington, VT
University Of Vermont Medical Center Inc

Providers in University Of Vermont Medical Center Inc

1.Yasmeen Abdul-karim

111 Colchester Ave
Burlington Vt 05401-1473
University Of Vermont Medical Center Inc
Psychiatry

2.Kevin Abnet Md

111 Colchester Ave
Burlington Vt 05401-1473
University Of Vermont Medical Center Inc
Anesthesiology

3.Amer Abu Alfa

111 Colchester Ave
Burlington Vt 05401-1473
University Of Vermont Medical Center Inc
Pathology

4.Wasef Abujaish

111 Colchester Ave
Burlington Vt 05401-1473
University Of Vermont Medical Center Inc
General Surgery

5.Wasef Abujaish

1 S Prospect St
Burlington Vt 05401-3456
University Of Vermont Medical Center Inc
General Surgery

6.Adam Ackerman

111 Colchester Ave
Burlington Vt 05401-1473
University Of Vermont Medical Center Inc
General Surgery

View all 992 members of University Of Vermont Medical Center Inc medical group